Table 1.
Grouping | N | RHS Median (IQR) | RHS Range | HFMSE Median (IQR) | HFMSE Range | Age Median (IQR) | Age Range | |
---|---|---|---|---|---|---|---|---|
All | 177 | 12 (6–34) | 0–69 | 18 (7–40) | 0–66 | 7.7 (4–10.6) | 1–17.5 | |
SMA Type | 2 | 110 | 7 (4–11) | 0–27 | 9 (4–18) | 0–39 | 6 (3–9.6) | 1–17.5 |
3a | 58 | 40 (25–48) | 7–67 | 47 (35–51) | 7–63 | 8.8 (5.3–11.5) | 2.7–15.7 | |
3b | 9 | 59 (49–64) | 31–69 | 60 (53–63) | 36–66 | 13.3 (9.4–15.2) | 4.2–17.1 | |
Age Group | <5 | 60 | 10 (6–23) | 3–52 | 16 (9–34) | 3–53 | 3.2 (2.2–4) | 1–4.9 |
5–7 | 33 | 15 (7–46) | 3–67 | 22 (10–49) | 3–63 | 6.3 (5.5–7.3) | 5–7.9 | |
8–13 | 64 | 16 (5–38) | 0–65 | 21 (6–44) | 0–63 | 9.8 (9.1–11.8) | 8–13.9 | |
14–18 | 20 | 6 (3–27) | 0–69 | 7 (3–38) | 0–66 | 14.9 (14.6–16.1) | 14.2–17.5 | |
WHO-derived Functional Group | Non–Sitter | 22 | 2 (1–4) | 0–8 | 2 (0–4) | 0–12 | 10.3 (6.4–12.6) | 1–16.5 |
Sitter | 98 | 8 (6–15) | 2–26 | 12 (7–20) | 2–40 | 5.8 (3.3–9.6) | 1.2–17.5 | |
Transitional Group | 11 | 26 (25–29) | 18–59 | 36 (34–38) | 24–61 | 8.7 (6.3–13.1) | 2.8–17.1 | |
Walker | 46 | 46 (41–58) | 27–69 | 49 (47–58) | 35–66 | 8.1 (4.8–10.1) | 2.7–15.2 | |
Ambulation | Non– Ambulant |
131 | 8 (4–15) | 0–59 | 11 (5–21) | 0–61 | 7.6 (3.8–10.9) | 1–17.5 |
Gender | Male | 94 | 10 (5–24) | 0–69 | 14 (7–34) | 0–66 | 7.9 (4.5–11.1) | 1–17.5 |
Female | 83 | 15 (6–40) | 0–67 | 21 (9–45) | 0–63 | 7.3 (3.6–9.9) | 1.2–16.6 | |
Spinal Surgery | Yes | 23 | 5 (2–10) | 0–59 | 6 (2–13) | 0–61 | 13.5 (10.2–14.9) | 2.2–17.5 |
No | 126 | 14 (6–36) | 0–69 | 20 (9–41) | 0–66 | 6.3 (3.6–9.5) | 1–15.7 | |
RHS Total Score Group | Q1 | 36 | 3 (2–4) | 0–4 | 3 (1–4) | 0–8 | 9.8 (4.9–13.8) | 1.5–16.6 |
Q2 | 38 | 6 (6–7) | 5–9 | 9 (7–11) | 4–16 | 6.1 (2.5–9.6) | 1–17.5 | |
Q3 | 38 | 14 (10–16) | 10–18 | 19 (15–23) | 11–29 | 5.1 (3.7–8.6) | 1.5–15.7 | |
Q4 | 34 | 28 (25–39) | 20–42 | 38 (34–46) | 27–49 | 9.3 (4.6–10.9) | 2.2–16.3 | |
Q5 | 31 | 56 (46–64) | 43–69 | 56 (50–62) | 36–66 | 7.9 (5.5–10.1) | 3.3–17.1 |